Manufacturer sues FDA for ‘irreparable harm’ despite PMTA reconsideration

Florida-based e-cigarette manufacturer Bidi Vapor has taken the US Food and Drug Administration (FDA) to court claiming it suffered “continued irreparable harm” from being given a marketing denial order (MDO) for its vaping products despite the agency having put the company’s application back under review.

A motion for “stay pending review” filed with the US Court of Appeals for the Eleventh Circuit in Atlanta, Georgia claims Bidi faces “immense financial losses” as a result of the MDO issued by the FDA in response to its premarket tobacco product application (PMTA).

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization